PATENT CLAIM ANALYSIS

Application Number: 15755390
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-09
Patent Classification: ["514", "217010"]

Abstract:
The present invention provides novel means and methods for treatment auf immunemediated inflammatory diseases.

Claim (Index 2):
Compounds for the use according to  claim 1 , characterized in that\n R 2  is hydrogen and R 3  is a side chain of an amino acid selected from the group comprising hydrogen; linear or branched C 1 -C 4 -alkyl; linear or branched alkyl groups of the type \u2014C n H 2n \u2014U-D wherein n is 1, 2, 3 or 4, U is selected from the group comprising O, CO, COO, CONH, S, guanidine and/or NH, and D is selected from the group comprising H and/or methyl; \u2014CH 2 \u2014C 6 H 4 \u2014OH; \u2014CH 2 -imidazole and/or \u2014CH 2 -indole; or R 3  and R 4  together with the ring atoms to which they are attached form a 5-membered non aromatic heterocycle having one N atom;

Metadata:
- Claim Count in Document: 1.0
- Percentile: 88.0
- Lexical Diversity: 1.0
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['11901843', '09886773', '12786221', '11801473', '13567146']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7495769011744221
- 35 USC 102 Novelty (BERT): 0.4945090449527765
- Combined Prediction Score: 0.7240701155522575
- Mean Citation Score: 226.707182
- Max Citation Score: 232.65176
- Similarity Product: 168.0138708193207

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test